{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:19:00Z","timestamp":1793319540468,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02768-z","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T09:04:32Z","timestamp":1673600672000},"page":"399-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura"],"prefix":"10.1007","volume":"55","author":[{"given":"Xiang-ting","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"issue":"21","key":"2768_CR1","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129(21):2836\u20132846","journal-title":"Blood"},{"issue":"1","key":"2768_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1182\/asheducation-2018.1.539","volume":"2018","author":"K Dane","year":"2018","unstructured":"Dane K, Chaturvedi S (2018) Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura. Hematol Am Soc Hematol Educ Progr 2018(1):539\u2013547","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2768_CR3","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"HJ Kremer","year":"2017","unstructured":"Kremer HJ, Coppo P, Lammle B et al (2017) Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers 3:17020","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2768_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/jth.13764","volume":"15","author":"M Saha","year":"2017","unstructured":"Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost 15(10):1889\u20131900","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2768_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tmrv.2019.06.005","volume":"33","author":"MA Mazepa","year":"2019","unstructured":"Mazepa MA, Park YA, Raval JS (2019) Taking empiricism out of immune thrombotic thrombocytopenic purpura: current and future treatment strategies. Transfus Med Rev 33(4):248\u2013255","journal-title":"Transfus Med Rev"},{"issue":"4","key":"2768_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F et al (2019) Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med 380(4):335\u2013346","journal-title":"N Engl J Med"},{"issue":"13","key":"2768_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1182\/blood.2020007599","volume":"137","author":"T Dutt","year":"2021","unstructured":"Dutt T, Shaw RJ, Stubbs M et al (2021) Real-world experience with caplacizumab in the management of acute TTP. Blood 137(13):1731\u20131740","journal-title":"Blood"},{"issue":"10","key":"2768_CR8","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1111\/jth.15010","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR et al (2020) ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost 18(10):2496\u20132502","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2768_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/rth2.12160","volume":"3","author":"P Coppo","year":"2019","unstructured":"Coppo P, Cuker A, George JN (2019) Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine. Res Pract Thromb Haemost 3(1):26\u201337","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"2768_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1182\/bloodadvances.2021005124","volume":"6","author":"J van den Berg","year":"2022","unstructured":"van den Berg J, Kremer HJ, Pfleger C et al (2022) Daratumumab for immune thrombotic thrombocytopenic purpura. Blood Adv 6(3):993\u2013997","journal-title":"Blood Adv"},{"issue":"4","key":"2768_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.tmrv.2022.09.001","volume":"36","author":"M Chen","year":"2022","unstructured":"Chen M, Shortt J (2022) Plasma cell directed therapy for immune thrombotic thrombocytopenic purpura (iTTP). Transfus Med Rev 36(4):204\u2013214","journal-title":"Transfus Med Rev"},{"issue":"10","key":"2768_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","volume":"130","author":"JE Sadler","year":"2017","unstructured":"Sadler JE (2017) Pathophysiology of thrombotic thrombocytopenic purpura. Blood 130(10):1181\u20131188","journal-title":"Blood"},{"issue":"3","key":"2768_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/jcm10030536","volume":"10","author":"S Sukumar","year":"2021","unstructured":"Sukumar S, Lammle B, Cataland SR (2021) Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med 10(3):536","journal-title":"J Clin Med"},{"issue":"2","key":"2768_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"M Scully","year":"2017","unstructured":"Scully M, Cataland S, Coppo P et al (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15(2):312\u2013322","journal-title":"J Thromb Haemost"},{"key":"2768_CR15","doi-asserted-by":"publisher","first-page":"851316","DOI":"10.3389\/fimmu.2022.851316","volume":"13","author":"Y Cui","year":"2022","unstructured":"Cui Y, Wei J, Peng X (2022) Case report: rabies vaccine-induced thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Front Immunol 13:851316","journal-title":"Front Immunol"},{"key":"2768_CR16","doi-asserted-by":"publisher","first-page":"107602961882530","DOI":"10.1177\/1076029618825309","volume":"25","author":"W Owattanapanich","year":"2019","unstructured":"Owattanapanich W, Wongprasert C, Rotchanapanya W et al (2019) Comparison of the long-term remission of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Clin Appl Thromb Hemost 25:1076029618825309","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"2768_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/ejh.13107","volume":"101","author":"BS Joly","year":"2018","unstructured":"Joly BS, Coppo P, Veyradier A (2018) Pediatric thrombotic thrombocytopenic purpura. Eur J Haematol 101(4):425\u2013434","journal-title":"Eur J Haematol"},{"issue":"1","key":"2768_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000517813","volume":"145","author":"T Palanques-Pastor","year":"2022","unstructured":"Palanques-Pastor T, Megias-Vericat JE, Boso RV et al (2022) Effectiveness of caplacizumab nanobody in acquired thrombotic thrombocytopenic purpura refractory to conventional treatment. Acta Haematol 145(1):72\u201377","journal-title":"Acta Haematol"},{"issue":"5","key":"2768_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/17474086.2020.1750361","volume":"13","author":"LA Gomez-De","year":"2020","unstructured":"Gomez-De LA, Villela-Martinez LM, Yanez-Reyes JM et al (2020) Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents. Expert Rev Hematol 13(5):461\u2013470","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"2768_CR20","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1002\/ajh.26022","volume":"96","author":"M Delrue","year":"2021","unstructured":"Delrue M, Baylatry MT, Joly AC et al (2021) Efficacy of subcutaneous preemptive rituximab in immune-mediated thrombotic thrombocytopenic purpura: experience from the first 12 cases. Am J Hematol 96(1):E26\u2013E29","journal-title":"Am J Hematol"},{"issue":"2","key":"2768_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/jth.14679","volume":"18","author":"P Knoebl","year":"2020","unstructured":"Knoebl P, Cataland S, Peyvandi F et al (2020) Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. J Thromb Haemost 18(2):479\u2013484","journal-title":"J Thromb Haemost"},{"issue":"43","key":"2768_CR22","doi-asserted-by":"publisher","first-page":"e12989","DOI":"10.1097\/MD.0000000000012989","volume":"97","author":"R Sun","year":"2018","unstructured":"Sun R, Gu W, Ma Y et al (2018) Relapsed\/refractory acquired thrombotic thrombocytopenic purpura in a patient with Sjogren syndrome: case report and review of the literature. Medicine (Baltimore) 97(43):e12989","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"2768_CR23","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.3324\/haematol.2021.279232","volume":"106","author":"E Crickx","year":"2021","unstructured":"Crickx E, Audia S, Robbins A et al (2021) Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia. Haematologica 106(12):3198\u20133201","journal-title":"Haematologica"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02768-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:55:52Z","timestamp":1679871352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02768-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"29 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}